Skip to main content

Remote Job Finders (RJF)

The investments come amid an ongoing insurance fraud probe into AstraZeneca’s former China head Leon Wang—and despite mounting pressure from President Trump for pharma companies to re-shore their manufacturing operations.
AstraZeneca Makes Potential $10B+ China Commitment Despite Political Pressure
Scroll to top